Stocks and Investing Stocks and Investing
Tue, January 24, 2023
[ 12:00 AM ] - United States, WOPRAI
Joshua Spector Upgraded (CC) to Strong Buy and Increased Target to $43 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Kenneth Worthington Upgraded (BX) to Buy and Increased Target to $105 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BX) at Buy with Decreased Target to $110 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BRDG) at Buy with Decreased Target to $20 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BNTX) at Hold with Increased Target to $216 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BOLT) at Hold with Decreased Target to $3 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Leshock Initiated (SPCE) at Hold on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (STEP) at Hold with Increased Target to $31 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Nathan Race Maintained (SRCE) at Buy with Decreased Target to $58 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Rollins Maintained (T) at Strong Buy with Increased Target to $22 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Arren Cyganovich Maintained (SYF) at Strong Buy with Increased Target to $45 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Scharf Maintained (SYF) at Buy with Increased Target to $42 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fotheringham Maintained (SYF) at Buy with Decreased Target to $53 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Moshe Orenbuch Maintained (SYF) at Buy with Decreased Target to $37 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Betsy Graseck Maintained (SYF) at Sell with Increased Target to $31 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Shannon Cross Maintained (STX) at Hold with Increased Target to $65 on, Jan 24th, 2023
Mon, January 23, 2023
[ 12:00 AM ] - United States, WOPRAI
Susan Roth Katzke Maintained (STT) at Hold with Increased Target to $84 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Betsy Graseck Maintained (STT) at Hold with Increased Target to $93 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Tim Long Upgraded (STX) to Buy and Increased Target to $70 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Blayne Curtis Upgraded (SWKS) to Buy and Increased Target to $125 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
David Amsellem Maintained (SUPN) at Buy with Increased Target to $47 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (SUN) at Buy with Increased Target to $51 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Jerry Revich Maintained (SUM) at Hold with Increased Target to $28 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Kevin Kumar Initiated (SPNS) at Strong Buy and Held Target at $28 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (SRE) at Hold with Decreased Target to $80 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Ramsey El-Assal Maintained (SQ) at Buy with Increased Target to $103 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Manuel Navas Maintained (SRCE) at Hold with Decreased Target to $51 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (SR) at Hold with Increased Target to $75 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (SO) at Sell with Increased Target to $64 on, Jan 23rd, 2023
[ 12:00 AM ] - United States, WOPRAI
Peter Lawson Maintained (BPMC) at Hold with Decreased Target to $44 on, Jan 23rd, 2023

Peter Lawson Maintained (BPMC) at Hold with Decreased Target to $44 on, Jan 23rd, 2023


Published on 2024-10-28 01:03:22 - WOPRAI, Peter Lawson
  Print publication without navigation


Peter Lawson of Barclays, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Decreased Target from $50 to $44 on, Jan 23rd, 2023.

Peter has made no other calls on BPMC in the last 4 months.



There are 10 other peers that have a rating on BPMC. Out of the 10 peers that are also analyzing BPMC, 4 agree with Peter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Derek Archila of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $41 on, Tuesday, January 3rd, 2023
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $52 on, Wednesday, November 2nd, 2022
  • Matthew Biegler of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 2nd, 2022
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $75 on, Wednesday, November 2nd, 2022


These are the ratings of the 6 analyists that currently disagree with Peter

  • Ami Fadia of "Needham" Initiated at Strong Buy and Held Target at $60 on, Wednesday, December 14th, 2022
  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $114 on, Friday, November 4th, 2022
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $108 on, Thursday, November 3rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $70 on, Wednesday, November 2nd, 2022
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $106 on, Wednesday, November 2nd, 2022
  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, November 2nd, 2022

Contributing Sources